| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 571045EIM4 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Matrix metalloproteinase 9 inhibitor | PubMed |
| Primary Target | |
|---|---|
| MMP9 |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Stomach Neoplasms | 3 | D013274 | ClinicalTrials |
| Colitis, Ulcerative | 2 | D003093 | ClinicalTrials |
| Crohn Disease | 2 | D003424 | ClinicalTrials |
| Arthritis, Rheumatoid | 2 | D001172 | ClinicalTrials |
| Cystic Fibrosis | 2 | D003550 | ClinicalTrials |
| Pulmonary Disease, Chronic Obstructive | 1 | D029424 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1518996-49-0 |
| ChEMBL | CHEMBL3833374 |
| FDA SRS | 571045EIM4 |
| Guide to Pharmacology | 9510 |
CONTENTS